Mill Creek Capital Advisors, LLC
Position in CNTX — Context Therapeutics Inc.
CIK 1964962
Conshohocken, PA
Position in CNTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$274,133
+$120,326 QoQ
Shares Held
104,631
0.0% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Mill Creek Capital Advisors, LLC holds $2,260,246 across 4 Biotechnology names. CNTX ranks #4 (12.1% of the industry book) .
All Filings in CNTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $274,133 | 104,631 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $153,807 | 104,631 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $101,387 | 104,631 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $68,533 | 104,631 | Shares | Sole | 2025-08-11 | |
| 2024-12-31 | $109,862 | 104,631 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $205,076 | 104,631 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $209,785 | 104,631 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $144,390 | 104,631 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $118,233 | 104,631 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $157,992 | 104,631 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $167,409 | 104,631 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $58,802 | 104,631 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $68,219 | 104,631 | Shares | Sole | 2023-05-25 | |
| No filing history on record for this holder in this stock. | ||||||